Last viewed: GLAXF


Prices are updated after-hours


nasdaq:GLAXF GLAXOSMITHKLINE PLC

GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (8.0% 1m) (22.3% 1y) (0.0% 2d) (1.9% 3d) (4.1% 7d) (673.55% volume)
http://gsk.com
Sec Filling | Patents | n/a employees

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

add to today's watch list email alert is off




brands   hepatitis   infectious disease   respiratory   vaccine   battery   batteries   pain relief   gastrointestinal   skin  

Press-releases


BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
LLY | $250.28 | twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: 0.0%
AMRX | $4.61 | twitter stocktwits trandingview |
Health Technology
| | O: -1.71% H: 0.0% C: 0.0%
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: -2.14% H: 0.0% C: 0.0%
GILD | $71.91 | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.0% C: 0.0%
GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology
| | O: -1.67% H: 3.62% C: 3.62%
PPG | $165.915 | twitter stocktwits trandingview |
Process Industries
| | O: -2.07% H: 0.0% C: 0.0%
AMGN | $230.86 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%
PHAT | $14.8 | twitter stocktwits trandingview |
Health Technology
| | O: -3.08% H: 0.0% C: 0.0%
JNJ | News | $168.61 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%
GSK | $45.29 | twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 0.0% C: 0.0%

space spac
41% of Growth to Originate from North America for Microbial Products Market |Evolving Opportunities with bioMerieux SA, GlaxoSmithKline Plc & Kyowa Hakko Bio Co. Ltd. |17000+ Technavio Reports
Published: 2022-01-13 (Crawled : 05:00) - prnewswire.com
NVS | $90.4 | twitter stocktwits trandingview |
Health Technology
| | O: 1.31% H: 0.0% C: 0.0%
TMO | News | $594.8 | twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 0.19% C: -3.81%
SNY | News | $51.51 | twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 0.0% C: 0.0%
SNYNF | News | $104.92 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%
GSK | $45.29 | twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 0.0% C: 0.0%

america growth
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
SNYNF | News | $104.92 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%
GSK | $45.29 | twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 0.0% C: 0.0%
VIR | $38.7 | twitter stocktwits trandingview |
Health Technology
| | O: 1.05% H: 1.98% C: -6.88%
SNY | News | $51.51 | twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 0.0% C: 0.0%
XNCR | $37.05 | twitter stocktwits trandingview |
Health Technology
| | O: 0.38% H: 1.12% C: -1.31%

covid-19 treatment fda application covid authorization merge
Global End Stage Renal Disease Market 2021-2027: Low Maintenance Dialysis Equipment and Artificial Kidneys are Expected to Drive Market Growth
Published: 2022-01-11 (Crawled : 17:00) - prnewswire.com
MDT | News | $108.105 | twitter stocktwits trandingview |
Health Technology
| | O: 0.48% H: 0.0% C: 0.0%
SNY | News | $51.51 | twitter stocktwits trandingview |
Health Technology
| | O: 1.58% H: 0.0% C: 0.0%
GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 0.0% C: 0.0%
AMGN | $230.86 | twitter stocktwits trandingview |
Health Technology
| | O: 0.71% H: 0.0% C: 0.0%
NVS | $90.4 | twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.0% C: 0.0%
SNYNF | News | $104.92 | twitter stocktwits trandingview |
Health Technology
| | O: -3.41% H: 5.99% C: 1.1%
GSK | $45.29 | twitter stocktwits trandingview |
Health Technology
| | O: -0.37% H: 0.0% C: 0.0%
BMY | $64.93 | twitter stocktwits trandingview |
Health Technology
| | O: -0.41% H: 0.0% C: 0.0%


GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply of Sotrovimab, Authorized for the Early Treatment of COVID-19
Published: 2022-01-11 (Crawled : 12:30) - globenewswire.com
GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 0.0% C: 0.0%


Global Depression Drugs Market to Surpass US$ 15,379.0 Million by 2028, Says Coherent Market Insights
Published: 2022-01-07 (Crawled : 19:00) - prnewswire.com
PFE | $54.98 | twitter stocktwits trandingview |
Health Technology

AZNCF | $118.1 | twitter stocktwits trandingview |
Health Technology

SNYNF | News | $104.92 | twitter stocktwits trandingview |
Health Technology

TAK | $14.75 | twitter stocktwits trandingview |
Health Technology

SNY | News | $51.51 | twitter stocktwits trandingview |
Health Technology

LLY | $250.28 | twitter stocktwits trandingview |
Health Technology

GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology

GSK | $45.29 | twitter stocktwits trandingview |
Health Technology

AZN | News | $58.2 | twitter stocktwits trandingview |
Health Technology

JNJ | News | $168.61 | twitter stocktwits trandingview |
Health Technology

drug depression
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology
| | O: -2.58% H: 1.2% C: 0.05%
LEGN | $41.5 | twitter stocktwits trandingview |
Health Technology
| | O: -7.55% H: 3.65% C: 3.07%
AMGN | $230.86 | twitter stocktwits trandingview |
Health Technology
| | O: -0.64% H: 0.67% C: 0.01%
GILD | $71.91 | twitter stocktwits trandingview |
Health Technology
| | O: -0.96% H: 0.58% C: -0.12%
XLO | $14.52 | twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.33% H: 5.33% C: -4.47%
GSK | $45.29 | twitter stocktwits trandingview |
Health Technology
| | O: -0.96% H: 0.0% C: 0.0%
FATE | $43.28 | twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 2.27% C: -4.25%
AKRO | $22.26 | twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 4.23% C: 3.03%

era therapeutics
Global Hepatorenal Syndrome Treatment Market Research Report (2021 to 2026) - by Type, Treatment, End-user and Region
Published: 2022-01-04 (Crawled : 21:00) - prnewswire.com
GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 1.57% C: 0.28%
MDT | News | $108.105 | twitter stocktwits trandingview |
Health Technology
| | O: 1.01% H: 0.0% C: 0.0%
BDX | News | $260.975 | twitter stocktwits trandingview |
Health Technology
| | O: -0.76% H: 0.0% C: 0.0%
SNY | News | $51.51 | twitter stocktwits trandingview |
Health Technology
| | O: 0.91% H: 0.0% C: 0.0%
SNYNF | News | $104.92 | twitter stocktwits trandingview |
Health Technology
| | O: 3.68% H: 0.0% C: 0.0%
JNJ | News | $168.61 | twitter stocktwits trandingview |
Health Technology
| | O: 0.52% H: 0.0% C: 0.0%
GSK | $45.29 | twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 0.0% C: 0.0%
BAX | News | $85.74 | twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.0% C: 0.0%
CPIX | $3.99 | twitter stocktwits trandingview |
Health Technology
| | O: -13.36% H: 0.0% C: 0.0%
EW | $118.26 | twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 0.0% C: 0.0%
LJPC | $4.92 | twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 4.19% C: -6.06%
BIVI | $4.47 | twitter stocktwits trandingview |
Health Technology
| | O: 2.86% H: 12.1% C: 12.1%

treatment renal research
Global Drug Delivery Devices Market Research Report (2021 to 2026) - by Route of Administration, Vehicles, Application, End-user and Region
Published: 2022-01-04 (Crawled : 17:00) - prnewswire.com
GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology
| | O: -3.82% H: 1.65% C: 0.04%
BDX | News | $260.975 | twitter stocktwits trandingview |
Health Technology
| | O: 1.06% H: 0.0% C: 0.0%
MMM | $178.74 | twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.1% H: 0.0% C: 0.0%
SNY | News | $51.51 | twitter stocktwits trandingview |
Health Technology
| | O: -2.03% H: 0.0% C: 0.0%
OSUR | $8.51 | twitter stocktwits trandingview |
Health Technology
| | O: 0.23% H: 0.0% C: 0.0%
ATRS | $3.57 | twitter stocktwits trandingview |
Health Technology
| | O: 0.56% H: 0.0% C: -2.51%
PANA | $9.731 | twitter stocktwits trandingview |
Finance
| | O: 0.72% H: 0.0% C: -0.72%
JNJ | News | $168.61 | twitter stocktwits trandingview |
Health Technology
| | O: 0.51% H: 0.0% C: 0.0%
GSK | $45.29 | twitter stocktwits trandingview |
Health Technology
| | O: -0.23% H: 0.62% C: -0.07%
BAX | News | $85.74 | twitter stocktwits trandingview |
Health Technology
| | O: 0.13% H: 1.18% C: 1.17%
WST | $379.78 | twitter stocktwits trandingview |
Health Technology
| | O: -0.79% H: 0.66% C: -3.03%
PHG | News | $34.11 | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.0% C: 0.0%
ABT | News | $130.53 | twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.0% C: 0.0%
PODD | $242.71 | twitter stocktwits trandingview |
Health Technology
| | O: 2.92% H: 2.2% C: -1.17%

application ces drug device research liver vehicles drug delivery
Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Directors
Published: 2021-12-27 (Crawled : 22:00) - biospace.com/
GSK | $45.29 | twitter stocktwits trandingview |
Health Technology
| | O: 0.39% H: 0.43% C: 0.36%
BVXV | $1.66 | twitter stocktwits trandingview |
Health Technology
| | O: -17.63% H: 2.62% C: 1.75%
GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology
| | O: 5.52% H: 0.0% C: -4.05%

vaccine
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying